1. Conformationally constrained farnesoid X receptor (FXR) agonists: heteroaryl replacements of the naphthalene.
- Author
-
Bass JY, Caravella JA, Chen L, Creech KL, Deaton DN, Madauss KP, Marr HB, McFadyen RB, Miller AB, Mills WY, Navas F 3rd, Parks DJ, Smalley TL Jr, Spearing PK, Todd D, Williams SP, and Wisely GB
- Subjects
- Animals, Binding Sites, Blood Glucose metabolism, Crystallography, X-Ray, Diabetes Mellitus, Experimental metabolism, Dogs, Fluorescence Resonance Energy Transfer, Humans, Isoxazoles chemical synthesis, Isoxazoles pharmacokinetics, Ligands, Mice, Molecular Conformation, Protein Structure, Tertiary, Quinolines chemical synthesis, Quinolines pharmacokinetics, Rats, Receptors, Cytoplasmic and Nuclear metabolism, Weight Gain drug effects, Isoxazoles chemistry, Naphthalenes chemistry, Quinolines chemistry, Receptors, Cytoplasmic and Nuclear agonists
- Abstract
To improve on the drug properties of GSK8062 1b, a series of heteroaryl bicyclic naphthalene replacements were prepared. The quinoline 1c was an equipotent FXR agonist with improved drug developability parameters relative to 1b. In addition, analog 1c lowered body weight gain and serum glucose in a DIO mouse model of diabetes., (Copyright © 2010 Elsevier Ltd. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF